The USG seeks information from stakeholders on available medical
countermeasures in development. BARDA is particularly interested in
products, technologies, and capabilities that have progressed into or
beyond clinical trials, have established large-scale cGMP manufacturing
capability, or utilize an approved platform.
These requests are for market research purposes only and are not
considered submissions for potential funding.